Your search returned 4 results.

Results
	1.	On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir. [electronic resource] by Kowdley, Kris V Nelson, David R Lalezari, Jacob P Box, Terry Gitlin, Norman Poleynard, Gary Rabinovitz, Mordechai Ravendhran, Natarajan Sheikh, Aasim M Siddique, Asma Bhore, Rafia Noviello, Stephanie Rana, Khurram Producer: 20171020 In: Liver international : official journal of the International Association for the Study of the Liver vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Sofosbuvir for previously untreated chronic hepatitis C infection. [electronic resource] by Lawitz, Eric Mangia, Alessandra Wyles, David Rodriguez-Torres, Maribel Hassanein, Tarek Gordon, Stuart C Schultz, Michael Davis, Mitchell N Kayali, Zeid Reddy, K Rajender Jacobson, Ira M Kowdley, Kris V Nyberg, Lisa Subramanian, G Mani Hyland, Robert H Arterburn, Sarah Jiang, Deyuan McNally, John Brainard, Diana Symonds, William T McHutchison, John G Sheikh, Aasim M Younossi, Zobair Gane, Edward J Producer: 20130528 In: The New England journal of medicine vol. 368 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. [electronic resource] by Nelson, David R Cooper, James N Lalezari, Jacob P Lawitz, Eric Pockros, Paul J Gitlin, Norman Freilich, Bradley F Younes, Ziad H Harlan, William Ghalib, Reem Oguchi, Godson Thuluvath, Paul J Ortiz-Lasanta, Grisell Rabinovitz, Mordechai Bernstein, David Bennett, Michael Hawkins, Trevor Ravendhran, Natarajan Sheikh, Aasim M Varunok, Peter Kowdley, Kris V Hennicken, Delphine McPhee, Fiona Rana, Khurram Hughes, Eric A Producer: 20150601 In: Hepatology (Baltimore, Md.) vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. [electronic resource] by Lawitz, Eric Lalezari, Jay P Hassanein, Tarek Kowdley, Kris V Poordad, Fred F Sheikh, Aasim M Afdhal, Nezam H Bernstein, David E Dejesus, Edwin Freilich, Bradley Nelson, David R Dieterich, Douglas T Jacobson, Ira M Jensen, Donald Abrams, Gary A Darling, Jama M Rodriguez-Torres, Maribel Reddy, K Rajender Sulkowski, Mark S Bzowej, Natalie H Hyland, Robert H Mo, Hongmei Lin, Ming Mader, Michael Hindes, Robert Albanis, Efsevia Symonds, William T Berrey, Michelle M Muir, Andrew Producer: 20130620 In: The Lancet. Infectious diseases vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)